QuantuMDx Group Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:QuantuMDx Group Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12341
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
QuantuMDx Group Ltd (QuantuMDx) is a developer of sciences tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious diseases, and companion diagnostics assays and tumour profiling. QuantuMDx also develops technologies such as Q-PREP, Q-AMP, Q-DETECT and Q-SEQ. The company’s devices are built using a range of complex technologies such as nanowires, microfluidic technologies and molecular biology technology. It serves clinics, pharmacies, hospitals and labs. The company has operations in the US and Singapore. QuantuMDx is headquartered in Newcastle Upon Tyne, the UK.

QuantuMDx Group Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QuantuMDx Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
QuantuMDx Raises USD8.4 Million in Venture Financing 11
Partnerships 12
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
Equity Offering 13
QuantuMDx Plans IPO 13
QuantuMDx Group Ltd – Key Competitors 14
QuantuMDx Group Ltd – Key Employees 15
QuantuMDx Group Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Sep 12, 2018: QuantuMDx announces senior management changes 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QuantuMDx Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
QuantuMDx Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
QuantuMDx Raises USD8.4 Million in Venture Financing 11
Foundation for Innovative New Diagnostics Enters into Agreement with QuantuMDx 12
QuantuMDx Plans IPO 13
QuantuMDx Group Ltd, Key Competitors 14
QuantuMDx Group Ltd, Key Employees 15
QuantuMDx Group Ltd, Other Locations 16
QuantuMDx Group Ltd, Subsidiaries 16

List of Figures
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QuantuMDx Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QuantuMDx Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[QuantuMDx Group Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PIQUR Therapeutics AG-製薬・医療分野:企業M&A・提携分析
    Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipe …
  • Kaiser Foundation Health Plan of Washington:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan of Washington - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Torishima Pump Mfg Co Ltd (6363):企業の財務・戦略的SWOT分析
    Torishima Pump Mfg Co Ltd (6363) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Great Bear Resources Ltd (GBR):企業の財務・戦略的SWOT分析
    Summary Great Bear Resources Ltd (GBRL) formerly Great Bear Uranium Corp, is a metals and mining company that offers minerals exploration and development services. The company acquires, mines, extracts, manages, explores, operates, produces, and develops uranium, gold, silver, base metals, and miner …
  • Compass Minerals International Inc (CMP):企業の財務・戦略的SWOT分析
    Compass Minerals International Inc (CMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Eurovia (SAS):企業の戦略・SWOT・財務情報
    Eurovia (SAS) - Strategy, SWOT and Corporate Finance Report Summary Eurovia (SAS) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Prime Healthcare Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prime Healthcare Services Inc (Prime Healthcare) is a hospital management center that operates acute care hospitals. The center provides medical services such as emergency room, senior services, heart care services, behavioral health services, and others. It offers surgical services, wound h …
  • IDL Biotech AB (IDL B):企業の財務・戦略的SWOT分析
    Summary IDL Biotech AB (IDL Biotech) is a biotechnology company that develops, manufactures and markets vitro diagnostic tests. The company offers products in the clinical areas of oncology and bacteriology. It offers vitro diagnostic tumor activity markers for common types of cancer which include b …
  • Booster Juice Ltd:企業の戦略・SWOT・財務情報
    Booster Juice Ltd - Strategy, SWOT and Corporate Finance Report Summary Booster Juice Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PNE Wind AG (PNE3):企業の財務・戦略的SWOT分析
    PNE Wind AG (PNE3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Fibra Uno Administracion SA de CV:企業の戦略・SWOT・財務情報
    Fibra Uno Administracion SA de CV - Strategy, SWOT and Corporate Finance Report Summary Fibra Uno Administracion SA de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Schneider National Inc (SNDR):企業の財務・戦略的SWOT分析
    Schneider National Inc (SNDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Japan Oil, Gas and Metals National Corp:企業の戦略的SWOT分析
    Japan Oil, Gas and Metals National Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Cofidis Participations S.A.
    Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report Summary Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Telconet S.A.:企業の戦略的SWOT分析
    Telconet S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Granit AD Skopje:企業の戦略・SWOT・財務情報
    Granit AD Skopje - Strategy, SWOT and Corporate Finance Report Summary Granit AD Skopje - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • AFC Energy plc (AFC):企業の財務・戦略的SWOT分析
    Summary AFC Energy Plc (AFC Energy) is a developer of alkaline fuel cells. The company's projects include Power-Up and Alkammonia. Its power generation technology is used in the industrial markets and produces heat, water, and electricity. AFC Energy provides its electricity for industrial applicati …
  • Dean Foods Co:戦略・SWOT・企業財務分析
    Dean Foods Co - Strategy, SWOT and Corporate Finance Report Summary Dean Foods Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Haitong Securities Co., Ltd.:企業のM&A・事業提携・投資動向
    Haitong Securities Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Haitong Securities Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Citizen Watch Co., Ltd. (7762):企業の財務・戦略的SWOT分析
    Citizen Watch Co., Ltd. (7762) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆